[Retracted] The Level of HbA1c Evaluates the Extent of Coronary Atherosclerosis Lesions and the Prognosis in Diabetes with Acute Coronary Syndrome

Table 4

Comparison of MACEs rates in the hospital and 12 months after discharge in the two groups.

(a)

	()	()
In-hospital clinical outcome
Recurrent ACS,	0	2	—	—
Target lesion revascularization,	1	2	—	—
Ventricular tachycardia/fibrillation,	2	3	—	—
Death, n	0	2	—	—
Total major adverse cardiac events,	3	9	0.564	0.453

(b)

	()	()
Clinical outcomes 12 months after discharge
Recurrent ACS,	1	5	—	—
Target lesion revascularization,	2	7	—	—
Death,	0	3	—	—
Total major adverse cardiac events,	3	15	4.128	0.022

Death, recurrent ACS, ventricular tachycardia/fibrillation, and target lesion revascularization were defined as the major adverse cardiac events.